Cyclopentatrimethylenemethane Diradicals
Diethyl 7-[6-(tert-Butyldiphenylsiloxy)hexylidene]-2,3-
diazabicyclo[2.2.1]heptane-2,3-dicarboxylate (Scheme 2,
Series 1, Step d). Carbamate (6.8 g, 79%) was prepared from
fulvene 18 (6.0 g, 14.9 mmol) according to general procedure
B. TLC Rf 0.21 (SiO2, 20% EtOAc/hexane), vanillin; IR (neat)
2933, 2857, 1746, 1703, 1462, 1428, 1372, 1312, 1186, 1109,
Bicyclo[5.3.0]dec-7-ene-2-carbaldehyde
(40)
and
3,3a,4a,5,6,7,8,8aOctahydro-2H-benzo[b]cyclopenta[d]fu-
ran (41; Scheme 7). Under the conditions described in general
procedure F, aldehyde 8 produced both 40 and 41 in a 9:1 ratio
in a total yield of 72-73%. With use of general procedure G,
aldehyde 8 produced only 41 in 74-75% yield. 40: TLC Rf
(SiO2, 10% EtOAc/hexane), vanillin; IR (neat) 2924, 2851, 2706,
1725, 1445, 1002, 795, 684, 653 cm-1 1H NMR (CDCl3, 400
0.60
867, 771 cm-1 1H NMR (CDCl3, 400 MHz) δ 7.68-7.64 (m,
;
;
4H, ArH), 7.45-7.35 (m, 6H, ArH), 5.30-5.29 (br m, 1H, Cd
CH), 4.91-4.87 (m, 1H, NCHCH2), 4.25-4.17 (br m, 5H,
NCHCH2, 2 × CH2CH3), 3.66-3.61 (m, 2H, CH2OTBDPS),
2.08-2.02 (m, 2H, CdCHCH2), 2.01-1.18 (m, 16H, CH2CH2-
CH2CH2OTBDPS, NCHCH2CH2CHN, 2 × CH2CH3), 1.06-
1.03 (br s, 9H, C(CH3)3). Due to the existence of a dynamic
equilibrium between isomers at room temperature, the peaks
are broad and few low-intensity peaks (equilibrating isomers)
are also observed: 13C NMR (CDCl3, 100 MHz) δ 159.2, 144.0,
138.2, 135.7, 134.2, 129.7, 127.7, 63.9, 62.8, 62.7, 53.6, 32.5,
29.5, 28.9, 27.0, 25.5, 25.4, 19.3, 14.6; ESI+/TOF m/z 601 (M+
+ Na); HRMS calcd for (C33H46N2O5Si + Na) 601.30682, found
601.3063.
MHz) δ 9.73 (d, J ) 0.8 Hz, 1H, CHO), 5.46 (m, 1H, CdCH),
3.25 (m, 1H, CdCCH), 2.96-2.83 (m, 1H, CHCHO), 2.67-1.21
(m, 12H); 13C NMR (100 MHz) δ 204.8, 148.1, 126.3 (126.1),
56.7 (55.32), 47.2 (47.0), 31.7 (31.4), 31.2 (30.9), 30.15 (30.10),
28.8 (28.9), 27.6 (27.5), 23.5; LREI-MS m/z 164 (M+), 146, 133,
122, 117, 105, 91, 79, 67, 53, 41; HRMS calcd for C11H16O
164.120115, found 164.120600. 41: TLC Rf 0.59 (SiO2, 10%
EtOAc/hexane), vanillin; IR (neat) 2929, 1695, 1047, 919, 877,
1
848, 798, 737, 722, 711, 691, 666 cm-1; H NMR (CDCl3, 400
MHz) δ 5.53 (dd, J ) 1.6, 3.2 Hz, 1H, CdCH), 5.08 (m, 1H,
CdCCH), 4.08 (m, 1H, OCHCHCdC), 2.52-2.35 (m, 3H,
allylic), 2.33-2.26 (m, 1H), 2.04-1.97 (m, 1H), 1.72-1.65 (m,
2H), 1.64-1.60 (m, 1H), 1.59-1.42 (m, 3H), 1.32-1.09 (m, 2H);
13C NMR (100 MHz) δ 153.3, 120.7, 86.59, 80.0, 39.0, 35.6,
33.8, 29.0, 26.0, 24.0, 20.1; LREI-MS m/z 164 (M+), 146, 136,
131, 121, 107, 93, 83, 77, 67, 53, 41; HRMS calcd for C11H16O
164.120115, found 164.120164.
Diethyl 7-(6-Hydroxyhexylidene)-2,3-diazabicyclo[2.2.1]-
heptane-2,3-dicarboxylate (21a; Scheme 2, Series 1, Step
e). TBDPS protected carbamate (6.5 g, 11.2 mmol) was
deprotected to give carbamate alcohol 21a (3.5 g, 94%) accord-
ing to general procedure C. TLC Rf 0.23 (SiO2, 50% EtOAc/
hexane), vanillin; IR (neat) 3472, 2935, 2858, 1710, 1464, 1400,
1-(2,4-Cyclopentadienyliden)-3-[2-(4-methoxyphenyl)-
(4R)-1,3-dioxolan-4-yl]propane (23; Scheme 2, Series 2,
Step a). Fulvene 23 (5.45 g, 91%) was prepared from aldehyde
2215 (5.0 g, 21.1 mmol) according to general procedure A. TLC
1374, 1316, 1245, 1188, 1148, 1106, 1057, 864, 770, 699 cm-1
;
1H NMR (CDCl3, 400 MHz) δ 5.28-5.20 (br m, 1H, CdCH),
4.85-4.79 (m, 1H, NCHCH2), 4.20-4.00 (br m, 5H, NCHCH2,
2 × CH2CH3), 3.54-3.47 (m, 2H, CH2OH), 2.36-2.27 (m, 3H,
CdCHCH2, OH), 2.03-1.89 (m, 16H, CH2CH2CH2CH2OH,
NCHCH2CH2CHN, 2 × CH2CH3). Due to the existence of a
dynamic equilibrium between isomers at room temperature,
the peaks are broad and few low-intensity peaks (equilibrating
isomers) are also observed; 13C NMR (CDCl3, 100 MHz) δ
158.9, 157.5, 144.0, 138.2, 117.4, 109.4, 62.4, 62.1, 60.4, 58.9,
32.4, 29.3, 28.6, 25.17, 25.10, 14.4, 14.1; ESI+/TOF m/z 363
(M+ + Na); HRMS calcd for (C17H28N2O5 + Na) 363.18904,
found 363.1885.
1
Rf 0.51 (SiO2, 20% EtOAc/hexane), vanillin; H NMR (CDCl3,
400 MHz) δ 7.44-7.35 (m, 2H, ArH), 6.93-6.87 (m, 2H, ArH),
6.59-6.38 (m, 4H, CpH), 6.20 (dt, J ) 5.0, 1.6 Hz, 1H, Cd
CH), 5.76 (s, 1H, OCHO), 4.32-4.21 (m, 2H, OCHHCHO), 3.82
(s, 3H, OCH3), 3.66-3.60 (m, 1H, OCHHCHO), 2.79-2.61 (m,
2H, CdCHCH2), 2.02-1.72 (m, 2H, CH2CH2CO); 13C NMR
(100 MHz) δ 160.7, 141.3, 133.6, 131.1, 128.2, 128.0, 125.7,
119.2, 113.96, 113.94, 104.2, 76.3, 70.0, 55.5, 33.6, 27.6; LREI-
MS m/z 284 (M+), 179, 153, 135, 132, 117, 105, 92, 77, 65, 51,
43; HRMS calcd for C18H20O3 284.14124, found 284.14114.
Diethyl 7-3-[2-(4-Methoxyphenyl)-(4R)-1,3-dioxolan-4-
yl]propylidene-2,3-diazabicyclo[2.2.1]heptane-2,3-dicar-
boxylate (Scheme 2, Series 2, Step b). Fulvene 23 (5.4 g,
19.0 mmol) was transformed into the carbamate (7.25 g, yellow
foam, 83%) as described in general procedure B. TLC Rf 0.25
(SiO2, 25% EtOAc/hexane), vanillin; IR (neat) 2980, 2938, 1742,
1702, 1615, 1588, 1516, 1373, 1306, 1247, 1187, 1105, 1030,
6-(2,3-Diazabicyclo[2.2.1]hept-2-en-7-yliden)-1-hex-
anol (21b; Scheme 2, Series 1, Step f). Carbamate alcohol
21a (3.4 g, 10.0 mmol) was transformed into diazene alcohol
21b (1.67 g, 86%) following general procedure D. TLC Rf 0.20
(SiO2, 100% ether), vanillin; IR (neat) 3398, 2933, 2857, 1643,
1480, 1439, 1282, 1114, 1052, 894, 854, 845, 740 cm-1; 1H NMR
(CDCl3, 400 MHz) δ 5.39 (app d, J ) 2.0 Hz, 1H, NCHCH2),
5.11 (overlapping t and d, J ) 7.6, 2.1 Hz, 2H, CdCH,
NCHCH2), 3.63 (dt, J ) 2.0, 6.5 Hz, 2H, CH2OH), 2.01 (br s,
1H, OH), 2.01-1.88 (m, 2H, CdCHCH2), 1.68-1.51 (m, 2H,
exo hydrogen on ethano bridge), 1.58-1.21 (m, 6H, CH2CH2CH2-
CH2OH), 1.06 (app d, J ) 8.8 Hz, 2H, endo hydrogen on ethano
bridge); 13C NMR (100 MHz) δ 146.9, 117.5, 72.8, 62.9, 55.2,
834, 773 cm-1 1H NMR (CDCl3, 400 MHz) δ 7.41-7.34 (m,
;
2H, ArH), 6.92-6.86 (m, 2H, ArH), 5.73 (s, 1H, OCHO), 5.24
(br m, 1H, CdCH), 4.92 (m, 1H, NCHCH2), 4.25-4.12 (m, 7H,
NCHCH2, CH2(O), 2 X CH2CH3), 3.80 (s. 3H, OCH3), 3.60 (m,
1H, CH2CH(O)), 2.33-2.11 (m, 2H, CdCHCH2), 1.97-1.48 (m,
6H, CdCHCH2CH2, NCHCH2CH2CHN) ,1.33-1.20 (m, 6H, 2
× CH2CH3). Due to the existence of a dynamic equilibrium
between isomers at room temperature, the peaks are broad
and few low-intensity peaks (equilibrating isomers) are also
observed: ESI+/TOF m/z 943 (2M+ + Na), 483 (M+ + Na),
461 (M+ + H), 325, 306, 270, 198; HRMS calcd for (C24H32N2O7
+ Na) 483.2117, found 483.21107.
32.6, 29.3, 29.1, 25.3, 21.7, 21.2; ESI+/TOF m/z 411 (2M+
+
Na), 389 (2M+ + H), 217 (M+ + Na), 195 (M+ + H), 167, 144;
HRMS calcd for (C11H18N2O + Na) 217.13113, found 217.1313.
6-(2,3-Diazabicyclo[2.2.1]hept-2-en-7-yliden)hexanal (8;
Scheme 2, Series 1, Step b). Doering oxidation of diazene
alcohol 21b (1.0 g, 5.1 mmol) to make diazene aldehyde 8
(0.89 g, 90%) was performed according to general procedure
E. TLC Rf 0.45 (SiO2, 100% ether), vanillin; IR (neat) 2940,
2860, 2722, 1719, 1479, 1441, 1390, 1284, 1113, 1085, 1041,
893, 847, 675 cm-1; 1H NMR (CDCl3, 400 MHz) δ 9.70 (t, J )
0.8 Hz, 1H, CHO), 5.33 (app d, J ) 1.2 Hz, 1H, NCHCH2),
5.07-5.03 (m, 2H, NCHCH2, and CdCH), 2.38 (dt, J ) 0.8,
7.2 Hz, 2H, CH2CHO), 1.96 (m, 2H, CdCHCH2), 1.61-1.49
(m, 4H, CH2CH2CHO, and exo hydrogen on ethano bridge),
1.35-1.27 (m, 2H, CH2CH2CH2CHO), 0.95 (app d, J ) 10.8
Hz, 2H, endo hydrogen on ethano bridge); 13C NMR (100 MHz)
δ 202.4, 145.3, 116.8, 76.9, 72.6, 43.6, 28.9, 28.8, 21.5, 21.4,
21.1; LRCI-MS m/z 193 (M+ + H), 165, 147, 135, 125, 120,
109, 97, 81, 67; HRMS calcd for (C11H16N2O + H) 193.134088,
found 193.134184.
7-3-[2-(4-Methoxyphenyl)-(4R)-1,3-dioxolan-4-yl]prop-
ylidene-2,3-diazabicyclo[2.2.1]hept-2-ene (Scheme 2, Se-
ries 2, Step c). Carbamate (7.1 g, 15.4 mmol) prepared as
described above was transformed into the diazene (3.92 g,
yellow oil, 81%) following general procedure D. TLC Rf 0.54
(SiO2, 100% ether), vanillin; IR (neat) 2941, 2887, 1614, 1517,
1303, 1248, 1170, 1079, 1034, 892, 830, 768, 735, 702 cm-1
;
1H NMR (CDCl3, 400 MHz) δ 7.40-7.30 (m, 2H, ArH), 6.91-
6.82 (m, 2H, ArH), 5.65 (s, 1H, OCHO), 5.36 (app d, J ) 3.0
Hz, 1H, NCHCH2), 5.01 (br m, 2H, CdCH, NCHCH2), 4.11-
3.94 (m, 2H, CHCH2O), 3.74 (s, 3H, OCH3), 3.60 (m, 1H,
(15) (a) Brimble, M. A.; Park, J. H.; Taylor, C. M. Tetrahedron 2003,
59 (31), 5861. (b) Shimizu, A.; Nishiyama, S. Synlett 1998, 11, 1209.
J. Org. Chem, Vol. 69, No. 25, 2004 8581